Rating History for Ultragenyx Pharma (RARE) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for RARE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/3/2026 Tazeen Ahmad Downgrade Neutral
(Buy)		 20.00
(48.00)		 26.53
(14.40)		 -45.72% Details